Keishu Murakami

Dr. Keishu Murakami


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2023 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
KMKeishu Murakami
Keishu Murakami
KSKen Sakamoto
Ken Sakamoto
HIHiroshi Ishiguchi
Hiroshi Ishiguchi
HIHidefumi Ito
Hidefumi Ito

24 July 2024 in Cureus
Verified
Journal Article
Open access
KMKeishu Murakami
Keishu Murakami
JKJinsoo Koh
Jinsoo Koh
SOShuhei Ogami
Shuhei Ogami
YAYohei Aoki
Yohei Aoki
KHKohei Hori
Kohei Hori
HIHidefumi Ito
Hidefumi Ito
Introduction: Sarcopenia is a skeletal muscle disease manifesting as low muscle mass and impaired muscle function. It has been reported that sarcopenia correlates with a low quality of life (QOL) and an increased risk of falls in patients with Parkinson's disease (PD). Nevertheless, few studies have investigated the prevalence, impact, and screening methods of sarcopenia in Japanese patients with PD. Methods: Sarcopenia was diagnosed based on the Asian Working Group for Sarcopenia 2019 consensus. We compared demographic characteristics, severity of PD, levodopa equivalent daily dose, QOL, fatigue, impulsive and compulsive behaviors, body mass index (BMI), calf circumference, skeletal muscle mass index (SMI), handgrip strength, a 4-meter gait speed, a five-time sit-to-stand test (FTSST), short physical performance battery, and SARC-F questionnaire scores between sarcopenia and non-sarcopenia groups. Furthermore, to investigate the best tool for screening sarcopenia in PD, the sensitivity and specificity of calf circumference, handgrip strength, FTSST, and SARC-F questionnaire were compared. Results: The prevalence of sarcopenia in PD was 31.9% (15/47). The sarcopenia group showed significantly higher age (77.3 +/- 5.12 versus 70.3 +/- 8.17, p = 0.0042), lower BMI (19.3 +/- 2.99 versus 23.3 +/- 3.18, p = 0.0002), higher rate of decreased calf circumference (86.6% versus 34.3%, p = 0.0013) and SMI (100% versus 6.25%, p < 0.0001), and worse FTSST (15.5 +/- 5.57 versus 12.0 +/- 4.12, p = 0.0219). The other parameters were not significantly different. Among screening tools, calf circumference had the highest sensitivity (86%) and specificity (65%). All screening tools had higher sensitivity and specificity in men than in women. The SARC-F questionnaire was not useful in distinguishing sarcopenia but was significantly correlated with the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale Part 3 (r = 0.41, p = 0.0037) and the 39-item Parkinson's Disease QOL Scale (r = 0.71, p < 0.0001). Conclusion: This study investigated the characteristics of PD patients with sarcopenia in Japan. Calf circumference was found to be the most useful tool for screening sarcopenia in PD. Handgrip strength and FTSST also showed high sensitivities, particularly in men. Conversely, the SARC-F questionnaire is not suitable for diagnosing sarcopenia in PD.

16 March 2024 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
KMKeishu Murakami
Keishu Murakami
KMKatsuichi Miyamoto
Katsuichi Miyamoto
JKJinsoo Koh
Jinsoo Koh
YKYoshinori Kajimoto
Yoshinori Kajimoto
HIHidefumi Ito
Hidefumi Ito

15 October 2022 in Internal Medicine
Verified
Journal Article
Closed access
PDF file
KMKeishu Murakami
Keishu Murakami
YKYoshinori Kajimoto
Yoshinori Kajimoto
HIHidefumi Ito
Hidefumi Ito
A 36-year-old man was admitted to our hospital with complaints of dysphagia and photophobia. A neurological examination showed oropharyngeal palsy and bilateral mydriasis with loss of light reflexes in the absence of external ophthalmoplegia. Bilateral pupils were supersensitive to pilocarpine 0.1%, which was compatible with Adie's tonic pupils. Serum IgG reacted with GQ1b, GT1a, GalNAc-GD1a, and GD3. Intravenous high-dose immunoglobulin therapy improved his neurological symptoms within three weeks. To our knowledge, there is no medical literature describing acute oropharyngeal palsy with Adie's tonic pupils. We recommend evaluating antiganglioside antibodies to clarify the cause of oropharyngeal palsy and Adie's tonic pupils.

6 July 2022 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
KMKeishu Murakami
Keishu Murakami
KMKatsuichi Miyamoto
Katsuichi Miyamoto
YHYasuhiro Hiwatani
Yasuhiro Hiwatani
YKYoshinori Kajimoto
Yoshinori Kajimoto
HIHidefumi Ito
Hidefumi Ito

14 September 2021 in Case Reports in Neurology
Verified
Journal Article
Open access
PDF file
KMKeishu Murakami
Keishu Murakami
JKJinsoo Koh
Jinsoo Koh
JTJunko Taruya
Junko Taruya
HIHidefumi Ito
Hidefumi Ito
A 67-year-old woman with a recurrent history of malignant lymphoma (ML) presented with muscle weakness and paresthesia of the fingertips and feet. Due to the elevated level of serum soluble interleukin-2 receptor and increased 18F-fluorodeoxyglucose uptake in a mediastinal lymph node, neurolymphomatosis was initially suspected. Neurological and electrophysiological examinations were consistent with mononeuropathy multiplex. A diagnosis of neurosarcoidosis was made based on the presence of noncaseating epithelioid granulomas in the mediastinal lymph node, along with the presence of the uveitis, cardiac inflammation, and mononeuropathy multiplex. She was treated with glucocorticoids and azathioprine, and her symptoms disappeared. Sarcoidosis following ML is rare, and since biopsy of nervous systems is often improbable, differentiating neurosarcoidosis and neurolymphomatosis can be difficult as their clinical symptoms can be similar. Clinicians should consider systemic pathological investigations based on 18F-fluorodeoxyglucose positron emission tomography examination in addition to comprehensive evaluation to accurately diagnose neurosarcoidosis.